通讯
Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial Carcinoma
Marcus J. Drake, Lori A. Birder
Imperial College London University of Pittsburgh
来源European Urology
年份2024
内容与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
110
126
关键指标
1
被引次数 · OpenAlex
-
领域内被引倍数
同类平均 = 1
同类平均 = 1
-
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
5
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
依据：文献信息 · 当前未解析全文
回答优先基于摘要、文献信息与可获取全文；依据不足时会明确说明。
学术脉络
学科主题
生物医学Bladder and Urothelial Cancer Treatments
Urinary Bladder and Prostate Research · Esophageal Cancer Research and Treatment
参考文献 5
Neural control of the lower urinary tract: Peripheral and spinal mechanisms
被引 174Lori A. Birder, William de Groat, Ian Mills · Neurourology and Urodynamics · 2009
Factors Influencing Lower Urinary Tract Symptoms in Advanced Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy
被引 8Ok‐Hee Cho, Yang‐Sook Yoo, Joon Chul Kim · International Neurourology Journal · 2018
Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER)
被引 102Paul Abrams, Lynda Constable, David Cooper · European Urology · 2021
此处列出前 3 条
施引文献 1
Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
被引 1Pan Ding, Qinghua Luo, Leihua Cao · Frontiers in Medicine · 2026
按被引量排序，此处列出前 3 条